October 2025 FDA Recall Niacin by Lannett Company Inc.
D-0096-2026 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Lannett Company Inc. on October 10, 2025 for the product Niacin. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0096-2026

Reason for Recall
Failed Dissolution Specifications
Initiated
10-10-2025
Reported
10-29-2025
Quantity
46,848 90-count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Lannett Company Inc.
Nationwide in the USA
Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46

Batch or Lot Expiration Information

Lot# Lot, expiry: 21264027A, Exp 10/30/2025; 22266446A, Exp 12/31/2025; 22266901A, Exp 02/28/2026; 22267553A, 22267554A, Exp 03/31/2026; 22267555A, Exp 02/28/2026; 22267992A, Exp 04/30/2026; 22267993A, 22267994A, Exp 05/31/2026